141 related articles for article (PubMed ID: 6173532)
1. ELectrophysiologic properties of bretylium tosylate on atrial myocardium.
Mirro MJ; Webel RR; Kelly KJ; Grina LA
J Cardiovasc Pharmacol; 1981; 3(6):1312-20. PubMed ID: 6173532
[TBL] [Abstract][Full Text] [Related]
2. Bretylium tosylate binds preferentially to muscarinic receptors labelled with [3H]oxotremorine M (SH or 'high affinity' receptors) in rat heart and brain cortex.
Gillard M; Brunner F; Waelbroeck M; Svoboda M; Christophe J
Eur J Pharmacol; 1989 Jan; 160(1):117-24. PubMed ID: 2714357
[TBL] [Abstract][Full Text] [Related]
3. Interaction of bretylium tosylate with rat cardiac muscarinic receptors. Possible pharmacological relevance to antiarrhythmic action.
Schreiber G; Friedman M; Sokolovsky M
Circ Res; 1984 Nov; 55(5):653-9. PubMed ID: 6488487
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic effects of bretylium tosylate on the canine heart during coronary artery occlusion and reperfusion.
Gibson JK; Stewart JR; Li YP; Lucchesi BR
J Cardiovasc Pharmacol; 1983; 5(4):517-24. PubMed ID: 6193345
[TBL] [Abstract][Full Text] [Related]
5. Membrane action and catecholamine release action of bretylium tosylate in normoxic and hypoxic canine Purkinje fibers.
Nishimura M; Watanabe Y
J Am Coll Cardiol; 1983 Aug; 2(2):287-95. PubMed ID: 6863763
[TBL] [Abstract][Full Text] [Related]
6. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
Kabell G
J Cardiovasc Pharmacol; 1989 Mar; 13(3):471-82. PubMed ID: 2471895
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of the effect of bretylium on the ventricular fibrillation threshold in dogs.
Euler DE; Scanlon PJ
Am J Cardiol; 1985 May; 55(11):1396-401. PubMed ID: 3993577
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptor heterogeneity revealed by interaction with bretylium tosylate. Different ligand-receptor conformations versus different receptor subclasses.
Schreiber G; Sokolovsky M
Mol Pharmacol; 1985 Jan; 27(1):27-31. PubMed ID: 3965929
[TBL] [Abstract][Full Text] [Related]
9. [Study of the electrophysiological properties of bretylium tosylate in man].
Touboul P; Porte J; Huerta F; Delahaye JP
Arch Mal Coeur Vaiss; 1976 May; 69(5):503-11. PubMed ID: 821420
[TBL] [Abstract][Full Text] [Related]
10. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
Anderson JL
Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
[TBL] [Abstract][Full Text] [Related]
11. Effects of bretylium tosylate on inhomogeneity of refractoriness and ventricular fibrillation threshold in canine hearts with quinidine-induced long QT interval.
Inoue H; Toda I; Nozaki A; Matsuo H; Sugimoto T
Cardiovasc Res; 1985 Oct; 19(10):655-60. PubMed ID: 4053141
[TBL] [Abstract][Full Text] [Related]
12. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
Heissenbuttel RH; Bigger JT
Ann Intern Med; 1979 Aug; 91(2):229-38. PubMed ID: 380436
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic effects of bretylium on canine ventricular muscle during acute ischemia and reperfusion.
Fujimoto T; Hamamoto H; Peter T; McCullen A; McCullen A; Melvin N; Mandel WJ
Am Heart J; 1983 Jun; 105(6):966-72. PubMed ID: 6858845
[TBL] [Abstract][Full Text] [Related]
14. Bretylium tosylate: a review.
Bryan CK; Darby MH
Am J Hosp Pharm; 1979 Sep; 36(9):1189-92. PubMed ID: 386786
[TBL] [Abstract][Full Text] [Related]
15. Effects of bretylium tosylate on electrophysiologic properties of normal and digitalized papillary muscles of guinea pigs.
Liu YC; Zhu PJ; Li ZY; Yu DZ
Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):526-8. PubMed ID: 8010051
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies of (--)-, (+/-)-propranolol, atenolol, guanethidine, bretylium and tetracaine on adrenergic transmission.
Kaiho M; Kubo T; Misu Y
Br J Pharmacol; 1981 Oct; 74(2):365-70. PubMed ID: 6274462
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of acetylcholinesterase with a bretylium tosylate photoaffinity probe.
Branchini BR; Lajiness EJ
Biochim Biophys Acta; 1986 Oct; 884(1):135-41. PubMed ID: 3768408
[TBL] [Abstract][Full Text] [Related]
18. Competitive inhibition of acetylcholinesterase by bretylium: possible mechanism for its induction of norepinephrine release.
Schreiber G; Sokolovsky M
J Cardiovasc Pharmacol; 1985; 7(6):1065-8. PubMed ID: 2418289
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of bretylium tosylate on electrical ventricular defibrillation in a controlled study.
Koo CC; Allen JD; Pantridge JF
Cardiovasc Res; 1984 Dec; 18(12):762-7. PubMed ID: 6518459
[TBL] [Abstract][Full Text] [Related]
20. Effects of bretylium on rat cardiac muscle: the electrophysiological effects and its uptake and binding in normal and immunosympathectomized rat hearts.
Namm DH; Wang CM; El-Sayad S; Copp FC; Maxwell RA
J Pharmacol Exp Ther; 1975 Apr; 193(1):194-208. PubMed ID: 1133764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
